TEPP-46, acting as a PKM2 agonist, increased the expression of PKM2 (red) in periodontitis tissues, while significantly inhibiting PKM2-positive osteoclasts (PKM2+TRAP+) (Fig. 6B). Here, ACP5 is linked to periodontitis.